Latest News and Press Releases

SEATTLE, April 07, 2025 (GLOBE NEWSWIRE) -- In a world where energy crashes, brain fog, and stubborn belly fat are all-too-common symptoms of unchecked blood sugar fluctuations, a new formula is...

SEATTLE, April 07, 2025 (GLOBE NEWSWIRE) -- If you’ve been brushing, flossing, rinsing—and still watching your dental health decline—there’s a reason. The truth is, most people never address the...

RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic...

Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in RheumatologyDual CD19/CD70 CAR T Specifically Designed to Enhance...

Aldeyra Therapeutics, Inc. investors that lost money are encouraged to contact BFA Law about its ongoing securities investigation.

PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload...

Daré unveiled its new dual-path approach for its proprietary Sildenafil Cream formulation after urging on the part of the healthcare community and hearing the demand from womenDaré is targeting...

– Company generated quarterly sequential growth with Q1 YCANTH® dispensed applicator units rising above 10,000 for the first time in a quarter – – As YCANTH distributor inventory levels have...

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain...

Teva and Samsung-Bioepis Launch Rare Disease Biosimilar in the U.S.

PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in...

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple...

CELEBRATION, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living...

-- AjD is a Mental Health Condition Triggered By a Stressful Life Event; Particularly Common in People with Serious Medical Illness -- -- AjD Represents an Area of Significant Unmet Need; No...

TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant...

RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...

-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2%...

Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in...

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

SAN FRANCISCO, April 06, 2025 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (NASDAQ: TMDX) reported blockbuster Q4 2024 earnings in late February 2025, booking $121.6 million in revenue (up 50%...

BOSTON, April 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with...

NEW YORK, April 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM)...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Actinium To Contact Him Directly To Discuss Their Options ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In GSK To Contact Him Directly To Discuss Their Options If you...

Wilmington, April 05, 2025 (GLOBE NEWSWIRE) -- When cognitive health is increasingly becoming a priority, the search for effective memory enhancement methods has never been more critical....

NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between...

TALLMADGE, Ohio, April 05, 2025 (GLOBE NEWSWIRE) -- NiteHush Pro is rapidly emerging as the go-to solution for those struggling with persistent snoring and dangerous sleep apnea. Snoring might seem...

Tampa, April 05, 2025 (GLOBE NEWSWIRE) -- In today’s fast-paced world, maintaining optimal health can often feel overwhelming. However, the rise of probiotics has revolutionized our approach to...

Sheridan, April 05, 2025 (GLOBE NEWSWIRE) -- Respiratory health has become a critical concern for many individuals, especially those suffering from chronic conditions like asthma and chronic...

Denver, April 05, 2025 (GLOBE NEWSWIRE) -- In an era where health and wellness are paramount, maintaining balanced blood sugar levels is crucial for overall well-being. VitaSeal emerges as a...

Tampa, April 05, 2025 (GLOBE NEWSWIRE) -- Many people turn to quick pharmaceutical fixes for nerve pain. But these often come with side effects and long-term risks. Nerve Freedom stands apart by...

Salt Lake City, April 05, 2025 (GLOBE NEWSWIRE) -- Maintaining optimal brain health today is more crucial than ever. With increasing stress levels, poor dietary habits, and a sedentary lifestyle,...

Denver, April 05, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced world, maintaining gut health is more crucial than ever. Poor digestive health can lead to a myriad of issues, from bloating and...

Akron, April 05, 2025 (GLOBE NEWSWIRE) -- Nitric Boost: The Quick Energy-Enhancing Solution for Daily Vitality Disclaimer: The following content is for informational purposes only and is not...

Aldeyra Therapeutics, Inc. investors that lost money are encouraged to contact BFA Law about its ongoing securities investigation.

New Data Demonstrate Proportion of Corrected M-AAT Reached a Mean of 91% of Total AAT in Circulation at Day 28 Following BEAM-302 Treatment in 60 mg Cohort (n=3) Mean Decrease of 79% in Mutant Z-AAT...

HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) -- Arialief is nutritional support specifically designed to offer sciatic nerve relief. It contains selected ingredients that work to alleviate the...

St. Petersburg, April 04, 2025 (GLOBE NEWSWIRE) -- As pet owners, we all want our furry companions to live long, healthy, and happy lives. One crucial aspect that contributes to their overall...

Las Vegas, April 04, 2025 (GLOBE NEWSWIRE) -- Testosterone, a critical hormone, plays a significant role in numerous bodily functions, including muscle development, energy levels, and mood...

Denver, April 04, 2025 (GLOBE NEWSWIRE) -- Many men face challenges related to energy levels, stamina, and confidence, which can significantly impact their quality of life. Enter BeastForce, a...

Denver, April 04, 2025 (GLOBE NEWSWIRE) -- Neuropathy, a condition affecting millions globally, manifests as nerve pain, tingling, and numbness, significantly impacting the quality of life....

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX). The...

Denver, April 04, 2025 (GLOBE NEWSWIRE) -- In a world increasingly focused on health and fitness, the quest for effective weight loss solutions has led many to explore natural...

Akron, April 04, 2025 (GLOBE NEWSWIRE) -- In today’s fast-paced world, respiratory health has become a growing concern for many individuals. With increasing pollution levels, lifestyle changes, and...

VANCOUVER, BC and KIBBUTZ YIFAT, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation...

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today...

WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations...

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...